CME Group to See 'Muted' Volume Growth in 2026, UBS Says

MT Newswires Live01-07

CME Group (CME) is likely to see "muted" volume growth of 5% this year, compared with 8% on average for the past five years, UBS Securities said in a note emailed Tuesday.

The brokerage's analysts cut their earnings per share estimate for Q4 of 2025 to $2.73 from $2.78 due to lower transaction revenues, driven by reduced futures volumes and marginally weaker-than-expected pricing trends, according to the note.

CME has not announced fee changes for 2026, given the recent data center outage, the analysts said.

As volumes return to normal in interest rate products, foreign exchange products, and energy products, companies like CME could outperform as they have significant exposure to growing volumes, the analysts added.

UBS maintains a neutral rating on the shares with a price target of $280.

Shares of CME fell 2.3% in recent Tuesday trading.

Price: 268.69, Change: -6.38, Percent Change: -2.32

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment